Published in Int J Urol on February 03, 2010
Response to the future of urodynamics: non-invasive ultrasound videourodynamics. Int J Urol (2010) 0.75
Evolutions of urodynamic studies: Toward less invasive and more physiological diagnostic tool. Urol Ann (2013) 0.75
Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol (2006) 1.78
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer. Cancer Immunol Immunother (2010) 1.70
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res (2005) 1.65
Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res (2007) 1.61
Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation (2006) 1.60
Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int (2010) 1.52
Editorial comment to Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study. Int J Urol (2012) 1.43
High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatments. Acta Med Okayama (2004) 1.42
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urol (2008) 1.41
Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology (2005) 1.35
Description of a 23.9-kilobase chromosomal deletion containing a region encoding fsr genes which mainly determines the gelatinase-negative phenotype of clinical isolates of Enterococcus faecalis in urine. Appl Environ Microbiol (2002) 1.34
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun (2007) 1.34
Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol (2004) 1.33
Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res (2008) 1.24
Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol (2004) 1.20
Usefulness of intraoperative fluorescence imaging to evaluate local anatomy in hepatobiliary surgery. J Hepatobiliary Pancreat Surg (2008) 1.17
Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem (2009) 1.17
Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology (2007) 1.14
Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002. Int J Urol (2007) 1.14
Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J (2013) 1.12
Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther (2007) 1.12
Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol (2009) 1.09
Pyogenic psoas abscess: difficulty in early diagnosis. Urol Int (2003) 1.07
Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa. J Bacteriol (2008) 1.06
Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol (2002) 1.05
REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med (2007) 1.04
Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping. Acta Med Okayama (2004) 1.04
Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem Biophys Res Commun (2009) 1.03
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients. Int J Cancer (2007) 1.03
Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats. Urology (2005) 1.02
Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol (2010) 1.01
Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem (2006) 1.01
Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer. Prostate (2006) 0.99
Phosphatidylinositol 4,5-bisphosphate stimulates vesicle formation from liposomes by brain cytosol. Proc Natl Acad Sci U S A (2002) 0.99
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. Cancer Immun (2003) 0.99
Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. Urology (2010) 0.99
Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol (2005) 0.99
Kidney function after nephrectomy for renal cell carcinoma. Urology (2004) 0.97
Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release. Cell Struct Funct (2007) 0.97
Robot-assisted laparoscopic radical prostatectomy in the Asian population: modified port configuration and ultradissection. Int J Urol (2010) 0.96
Minimal invasiveness and effectivity of subinguinal microscopic varicocelectomy: a comparative study with retroperitoneal high and laparoscopic approaches. Int J Urol (2005) 0.96
Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. J Infect Chemother (2007) 0.96
Laparoscopic management of complicated urachal remnants in adults. World J Urol (2012) 0.96
Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene. Mol Biotechnol (2014) 0.96
Botulinum toxin type A for the treatment of lower urinary tract disorders. Int J Urol (2012) 0.95
Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Med Oncol (2011) 0.95
A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents (2006) 0.95
Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama (2004) 0.95
Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma. Urol Int (2010) 0.95
Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci (2004) 0.94
Perivesical abscess caused by migration of a fish bone from the intestinal tract. Int J Urol (2002) 0.93
miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg. PLoS One (2011) 0.93
Long-term consequence of renal function following nephrectomy for renal cell cancer. Int J Urol (2004) 0.93
Tolerability and morbidity of urodynamic testing: a questionnaire-based study. Urology (2005) 0.93
Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder. Neurourol Urodyn (2008) 0.92
Hydronephrosis due to ureteral endometriosis treated by transperitoneal laparoscopic ureterolysis. Int J Urol (2004) 0.92
Clinical implications of biofilm formation by Enterococcus faecalis in the urinary tract. Acta Med Okayama (2005) 0.92
Distribution of dynamins in testis and their possible relation to spermatogenesis. Biochem Biophys Res Commun (2002) 0.91
Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J Infect Chemother (2013) 0.90
Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer. Int J Oncol (2009) 0.90
Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study. Scand J Urol Nephrol (2009) 0.90
Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm. J Infect Chemother (2002) 0.90
Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study. Int J Urol (2006) 0.89
Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. J Urol (2004) 0.89
Synergistic effect of fosfomycin and fluoroquinolones against Pseudomonas aeruginosa growing in a biofilm. Acta Med Okayama (2005) 0.89
Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. Hum Gene Ther (2005) 0.89
Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor. BJU Int (2006) 0.89
Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey. Acta Med Okayama (2007) 0.89
Amphiphysin 1 is important for actin polymerization during phagocytosis. Mol Biol Cell (2007) 0.89
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis. BJU Int (2008) 0.89
Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis. J Bacteriol (2006) 0.88
Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer. Acta Med Okayama (2008) 0.88
Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging. Oncol Rep (2011) 0.88
Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. Jpn J Clin Oncol (2004) 0.88
Clinical significance of CD24 as a predictor of bladder cancer recurrence. Oncol Lett (2013) 0.88
Down-regulation of BiP/GRP78 sensitizes resistant prostate cancer cells to gene-therapeutic overexpression of REIC/Dkk-3. Int J Cancer (2010) 0.87
Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients. Int J Antimicrob Agents (2008) 0.87
Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity. Int J Urol (2004) 0.87
An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis. Biochem Biophys Res Commun (2008) 0.87
REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. Int J Oncol (2012) 0.86
Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. J Gastroenterol Hepatol (2014) 0.86
Laparoscopic removal of Müllerian structures and orchiopexy for persistent Müllerian duct syndrome. Urology (2003) 0.86
Extracorporeal magnetic innervation treatment for urinary incontinence. Int J Urol (2004) 0.85
Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma. Urology (2004) 0.85
Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Prostate (2002) 0.85
Laparoscopic adrenalectomy in patients with large adrenal tumors. Int J Urol (2005) 0.85
[A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic non-bacterial prostatitis]. Nihon Hinyokika Gakkai Zasshi (2002) 0.85
XAGE-1 mRNA expression in prostate cancer and antibody response in patients. Microbiol Immunol (2005) 0.85
Comparative study of effects of extracorporeal magnetic innervation versus electrical stimulation for urinary incontinence after radical prostatectomy. Urology (2004) 0.85
p53 protein transduction therapy: successful targeting and inhibition of the growth of the bladder cancer cells. Eur Urol (2005) 0.84
A novel gene expression system for detecting viable bladder cancer cells. Int J Oncol (2012) 0.84
Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer. Oncol Rep (2008) 0.84